Cello Group reveal their £10m pre-tax profits amidst the price hike of generic drugs

  • Home
  • /
  • Podcasts
  • /
  • Cello Group reveal their £10m pre-tax profits amidst the price hike of generic drugs - 22 Mar 17
Nigel Cassidy

Cello Group reveal their £10m pre-tax profits amidst the price hike of generic drugs

Nigel Cassidy
Original Broadcast:

Share Radio Breakfast

Cello Group reveal their £10m pre-tax profits amidst the price hike of generic drugs
Cello Group, the UK based healthcare and consumer strategic marketing company has released their latest preliminary results today. Cello Group has two distinct businesses, Cello Health which delivers marketing advisory services to the global pharma and health sectors, and Cello Signal which delivers digitally-led insight and marketing services to global consumer and B2B clients. So how is the company doing? Mark Scott, CEO of Cello revealed to Nigel Cassidy.
Guest:

Mark Scott


Published:

Topics: UK (in Economics)

Strand: Share Radio Breakfast


Listen
View all podcasts